By Mariam Sunny and Bhanvi Satija (Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short of expectations on ...

Kenvue, Inc. ( (KVUE)) has released its Q3 earnings. Here is a breakdown of the information Kenvue, Inc. presented to its investors. Kenvue, Inc., the world’s largest pure-play consumer health company ...

During the last three months, 10 analysts shared their evaluations of Kenvue KVUE, revealing diverse outlooks from bullish to bearish. The table below provides a concise overview of recent ratings ...

Kenvue, Inc. is a consumer health company. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold ...

Mark Proulx, global director of media quality & responsibility, Kenvue (photo: Sean T. Smith) When advertisers see their ad verification partners blocking lots of impressions, they often think, “Okay, ...

SKILLMAN, N.J. (AP) — SKILLMAN, N.J. (AP) — Kenvue Inc. (KVUE) on Thursday reported third-quarter profit of $383 million. On a per-share basis, the Skillman, New Jersey-based company said it ...

Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna Lizzul from Bank of America Securities reiterated a Buy ...

Starboard Value just shook things up, taking a bold stake in Kenvue (NYSE:KVUE), the company behind everyday staples like Band-Aid, Listerine, and Tylenol. Since breaking away from Johnson ...

Kenvue said it now expects annual net sales to grow closer to the lower end of its forecast of 1% to 3% growth. It reaffirmed its annual per share profit forecast of between $1.10 and $1.20.